Umbilical cord blood transplantation has transformed the treatment options for patients with blood cancers and other life-threatening hematologic disorders, particularly when matched donors are unavailable. While cord blood is known for its ability to tolerate genetic mismatches better than other donor sources, severe immune complications remain a major barrier to long-term survival.
This article was originally published on MedicalXpress.com

